UNH
UNITEDHEALTH GROUP INC
NYSE: UNH · Eden Prairie, MN · Healthcare
$413.00+6.43 (+1.58%)Closed
Market Cap$374.75B
Cash$28.00Bmost recent
Runwayprofitable
P/E (TTM)31.2EPS $13.23
52-Wk Range$232.89 – $413.00
Avg Volume10.7M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$413.00-12.8%
Pipeline
Drug candidates sponsored by UNITEDHEALTH · ClinicalTrials.gov
| Phase | Drug / Candidate | Indications | Status | Next Completion | Trials | |
|---|---|---|---|---|---|---|
| Phase 4 | Unnamed | Childhood Obesity | Completed | 2012-09past | 1 | |
| Phase 2 | Group 1 HCQ | Coronavirus+1 more | Terminated | 2020-07-11past | 1 | |
| N/A | Unnamed | Childhood Obesity | Completed | 2012-06-05past | 1 | |
| N/A | Unnamed | Pre-diabetes | Completed | 2013-05past | 1 | |
| N/A | Unnamed | Infections, Respiratory+2 more | Completed | 2020-03-23past | 1 | |
| N/A | Unnamed | SARS-CoV Infection | Completed | 2020-08-18past | 1 | |
| N/A | Unnamed | PreDiabetes+1 more | Completed | 2021-10-26past | 1 |
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for UNH. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.